Preoperative administration of recombinant human erythropoietin in patients undergoing gynecologic surgery

Gynecologic and Obstetric Investigation

Volumn 54, Issue 1, 2002, Pages 1-5

  Sesti, Francesco ^a   Ticconi, Carlo ^a   Bonifacio, Simone ^a   Piccione, Emilio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Anemia; Erythropoietin; Gynecological surgery

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ABDOMINAL HYSTERECTOMY; ADULT; ANEMIA; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; GYNECOLOGIC SURGERY; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; OPERATION DURATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; VAGINAL HYSTERECTOMY;

ADULT; ANEMIA; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMOGLOBINS; HUMANS; HYSTERECTOMY; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 0036389406     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064688     Document Type: Article

References (27)

1. Hill DJ: Complications of hysterectomy. Ballières Clin Obstet Gynaecol 1997;11:181-197.
2. Benson KT: The Jehovah's Witness patient: Consideration for the anesthesiologist. Anesth Analg 1989;69:647-656.
3. Thompson FL, Powers JS, Graber SE, Krantz SB: Use of recombinant human erythropoietin to enhance autologous blood donation in a patient with multiple red cell allo-antibodies and the anemia of chronic disease. Am J Med 1990;90:398-400.
4. Rothstein P, Roye D, Verdisco L, Stern L: Pre-operative use of erythropoietin in an adolescent Jehovah's Witness. Anesthesiology 1990; 73:568-570.
5. Johnson PW, King R, Slevin ML, White H: The use of erythropoietin in a Jehovah's Witness undergoing major surgery and chemotherapy. Br J Cancer 1991;63:476.
6. Fullerton DA, Campbell DN, Whitman GJ: Use of human recombinant erythropoietin to correct severe preoperative anemia. Ann Thorac Surg 1991;51:825-826.
7. Kraus P, Lipman J: Erythropoietin in a patient following multiple trauma. Anesthesia 1992; 47:962-964.
8. Collins SL, Timberlake GA: Severe anemia in the Jehovah's Witness: Case report and discussion. Am J Crit Care 1993;2:256-259.
9. Akingbola OA, Custer JR, Bunchman TE, Sedman AB: Management of severe anemia without transfusion in a pediatric Jehovah's Witness patient. Crit Care Med 1994;22:524-528.
10. Sowade O, Warnke H, Shigalla P, Sowade B, Francke W, Messinger D: Avoidance of allogeneic blood transfusion by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 1997;89:411-418.
11. Sowade O, Gross J, Sowade B, Franke W, Messinger D, Ziebell E, Scigalla P, Warnke H: Evaluation of oxygen availability with oxygen status algorithm in patients undergoing open-heart surgery treated with epoetin beta. J Lab Clin Med 1997;129:97-105.
12. Sifakis S, Angelakis E, Vardaki E, Koumantaki Y, Matalliotakis I: Erythropoietin in the treatment of iron deficiency anemia during pregnancy. Gynecol Obstet Invest 2001;51:150-156.
13. Faris PM, Ritter MA, Abels RI: The effects of recombinant human erythropoietin on peri-operative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Group. J Bone Joint Surg Am 1996;78:62-66.
14. D'Ambra M: Perioperative epoietin alpha reduced transfusion requirements in coronary artery bypass graft surgery. Semin Hematol 1996; (suppl 2):73-76.
15. Qvist N, Boesby S, Wolff B, Hansen CP: Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: Reduced need for blood transfusions in patients undergoing colorectal surgery - prospective double-blind placebo-controlled study. World J Surg 1999;23:30-35.
16. Messmer K: Consensus statement: Using epoietin alpha to decrease the risk of allogenic blood transfusion in the surgical setting. Roundtable of Experts in Surgery Blood Management. Semin Hematol 1996;(2 Suppl 2):78-80.
17. Braga M, Gianotti A, Vignali A, Gentilini O, Servida P, Bordignon C, Di Carlo V: Evaluation of recombinant erythropoietin to facilitate autologous blood donation before surgery in anemic patients with cancer of the gastrointestinal tract. Br J Surg 1995;82:1637.
18. Heiss MH, Tarabichi A, Delanoff C, Allgayer H, Jauch KW, Hernandez-Richter T, Mempel W, Beck KG, Schildberg FW, Messmer K: Peri-surgical erythropoietin application in anemic patients with colorectal cancer: A double-blind randomized study. Surgery 1996;119:523.
19. Biesma DH, Van de Wiel A, Beguin Y, Kraayenhagen R, Marx JM: Postoperative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest 1995;25:383-389.
20. Zauber NP, Zauber AG, Gordon FJ, Tillis AC, Leeds HC, Berman E: Iron supplementation after femoral head replacement for patients with normal iron stores. JAMA 1992;267:525-527.
21. Lee GR: The anemia of chronic disease. Semin Hematol 1983;20:61-80.
22. Means RT Jr, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80:1639-1647.
23. Van Iperen CE, Kraaijenhagen RJ, Biesma DH, Beguin Y, Marx JJ, Van de Wiel A: Iron metabolism and erythropoiesis after surgery. Br J Surg 1998;85:41-45.
24. Kickler TS, Spivak JL: Effect of whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. JAMA 1998;260:65-70.
25. Stenver D, Jeppesen LL, Nielsen B: The effect of erythropoietin on platelet function and fibrinolysis in chronic renal failure. Int J Artif Organs 1994;17:141-145.
26. Biesma DH, Bronkhorst PJH, de Groot PG, et al: The effect of recombinant human erythropoietin on haemostasis, fibrinolysis and blood rheology in autologous blood donors. J Lab Clin Med 1994;124:42-47.
27. Poulsen KA, Qvist N, Winther K, Boesby S: Haemostatic aspects of recombinant human erythropoietin in colorectal surgery. Eur J Surg 1998;164:211-215.